Brief

The inspection of Centre Cardiologique du Nord in Saint-Denis revealed significant nonconformities and shortcomings. A letter was sent to the establishment on March 24, 2025, highlighting insufficiencies in document tracing, access to electronic documentation, and inconsistencies in source documents. The French National Agency for Medicines and Health Products Safety (ANSM) has ordered the Centre Cardiologique du Nord to implement corrective actions within specified deadlines, including updating their software systems and documentation to ensure compliance with Good Clinical Practices regulations.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies